Best Buy (BBY) has been an interesting stock to play over the years; it certainly has had its ups and downs! We can see from the weekly chart below that the swings since 2012 have been wild. However, the stock is now poised for a big run that could last through the new year. The…
DetailsWhen a seasoned trader sees a V bottom, they instinctively shudder. V bottoms rarely provide anyone who is trading markets a chance to get on board; it really messes with a trader’s mind. Unfortunately, we have been dealing with a V bottom recently in the form of a sharp drop followed by an eye-popping rally.…
Details
My special guest during this week’s webinar was seasoned investor Tim Melvin, a whip-smart guy and one of my colleagues at Realmoney.com. We talked about a wide variety of topics including the markets and trading of course, but we also touched on politics, sports, and scotch! Before I introduced Tim, I discussed the markets’ all…
DetailsAs stock derivatives, options offer traders some tremendous opportunities to play high-priced stocks or very active/liquid securities. Options are not only offered on equities but indices, futures and commodities as well. Market makers even use options as hedging vehicles (but that only works best when there is a lot of interest). The issue of interest…
Details
Curious as to how Trifecta Stocks are doing? Well, I am thrilled to report that the Trifecta Stocks portfolio is doing very nicely this year, owing much of its success to the quant, technical and fundamental approaches Bryan Ashenberg and I use to synthesize the trading markets and bring out the best of the best…
Details
Since mid-September, the volatility index (VIX) has been on a spectacular round trip, moving up from the low teens to 31 and then turning right back down again. Before the VIX took off to the upside on September 23, the indices were at/near all time highs. Today, we are still there, but the tone has…
DetailsAs we enter the last couple months of 2014, the markets are once again at/near all-time highs: The Nasdaq, which last hit 5K in 2000 before a dramatic decline, is now just 8% away from hitting that level. The Russell 2K, which was left for dead and blamed for leading the markets lower, is only…
Details
Brian Sozzi, a brilliant analyst with Belus Capital Advisors, joined us for this week’s webinar, and wow – he provided some really great insight on a handful of retail names (and other segments). He first explained the numerous challenges in a very tough retail environment, including economic data that seems to point to a coming…
Details
Cerner (CERN) is a big healthcare IT company in a very competitive industry. They recently reported earnings that were mostly in line with predictions but also provided some strong guidance. As a result, the stock has moved vertically into the low $60’s, and it appears there is more room to run. This month has brought…
Details
Celgene (CELG) is part of that volatile biotech group, and if you have the stomach for big swings, then you may be ready for a nice payoff (if you go long). You can see in the chart below that a MACD signal is about to be crossed. The recent power move up from low 80’s…
Details